- 3TC
lamivudine
- ABC
abacavir
- AFB
acid-fast bacilli
- AIDS
acquired immunodeficiency syndrome
- ALT
alanine aminotransferase
- a.m.
ante meridiem (denotes morning)
- ANC
antenatal care
- ART
antiretroviral therapy
- ARV
antiretroviral (drug)
- AST
aspartate aminotransferase
- ATV
atazanavir
- AUC
area under curve
- AZT
zidovudine (also known as ZDV)
- BAL
bronchoalveolar lavage
- BCG
bacille Calmette – Guérin (vaccine)
- BSA
body surface area
- CD4+
T-lymphocyte bearing CD4 receptor
- %CD4+
percent CD4+
- CDC
Centers for Disease Control and Prevention
- CHAP
Children with HIV Antibody Prophylaxis (clinical trial)
- CMV
cytomegalovirus
- CNS
central nervous system
- CPK
creatinine phosphokinase
- CRAG
cryptococcal antigen
- CSF
cerebrospinal fluid
- CTX
co-trimoxazole
- d4T
stavudine
- DART
Development of Antiretroviral Therapy (in Africa)
- DBS
dried blood spot
- ddI
didanosine
- DMPA
depot medroxyprogesterone acetate
- DNA
deoxyribonucleic acid
- DOT
directly observed therapy
- EC
enteric-coated
- EFV
efavirenz
- EIA
enzyme immunoassay
- EML
Essential Medicines List
- ELISA
enzyme-linked immunosorbent assay
- ETV
etravirine
- EU
European Union
- EWI
early warning indicator
- FDC
fixed-dose combination
- FPV
fos-amprenavir
- FTC
emtricitabine
- Grade
grading of recommendations assessment, development and evaluation
- HAART
highly active antiretroviral therapy
- HDL
high-density lipoprotein
- Hgb
haemoglobin
- HGC
hard gel capsule
- HIV
human immunodeficiency virus
- HIVDR
HIV drug resistance
- HIVNET
HIV Network for Prevention Trials
- HIVResNet
Global HIV Drug Resistance Network
- HSV
herpes simplex virus
- IDV
indinavir
- IMCI
integrated management of childhood illness
- INH
isoniazid
- IPT
isoniazid preventive therapy
- IRIS
immune reconstitution inflammatory syndrome
- LDH
lactate dehydrogenase
- LGE
lineal gingival erythema
- LIP
lymphocytic interstitial pneumonia
- LPV
lopinavir
- LTB
laryngotracheal bronchitis
- MCH
maternal-child health
- MDR
multidrug resistant
- MTCT
mother-to-child transmission (of HIV)
- MUAC
mid-upper arm circumference
- NAT
nucleic acid amplification test
- NFV
nelfinavir
- NNRTI
non-nucleoside reverse transcriptase inhibitor
- NPA
nasopharyngeal aspirate
- NRTI
nucleoside reverse transcriptase inhibitor
- NSAID
non-steroidal anti-inflammatory drug
- NVP
nevirapine
- OI
opportunistic infection
- PCP
Pneumocystis pneumonia
- PCR
polymerase chain reaction
- PENTA
Paediatric European Network for Treatment of AIDS
- PGL
persistent generalized lymphadenopathy
- PI
protease inhibitor
- p.m.
post meridiem (denotes afternoon)
- PMTCT
prevention of mother-to-child transmission (of HIV)
- /r
low-dose ritonavir
- RCT
randomized controlled trial
- RDA
recommended daily allowance
- REE
resting energy expenditure
- RNA
ribonucleic acid
- RT
reverse transcriptase
- RTI
reverse transcriptase inhibitor
- RTV
ritonavir
- RUTF
ready-to-use therapeutic feeds
- SD
standard deviation
- sd-NVP
single-dose nevirapine
- SQV
saquinavir
- T20
enfurvirtide
- TAM
thymidine analogue mutation
- TB
tuberculosis
- TDF
tenofovir disoproxil fumarate
- TEN
toxic epidermal necrolysis
- TLC
total lymphocyte count
- TPV
tipranavir
- TRG
Technical Reference Group on Paediatric HIV Care and Treatment
- TST
tuberculin skin test
- ULN
upper limit of normal
- UNAIDS
Joint United Nations Programme on HIV/AIDS
- UNICEF
United Nations Children's Fund
- Up24 Ag
ultrasensitive p24 antigen
- URTI
upper respiratory tract infection
- USAID
United States Agency for International Development
- WBC
white blood cell count
- WHO
World Health Organization
- XDR
extensively drug resistant
